Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,593 High Cholesterol
clinical trials

Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Mansfield, OH
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Morehead City, NC
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Provo, UT
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
South Bend, IN
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Tampa, FL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Toledo, OH
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Torrance, CA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Tyler, TX
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Winchester, VA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
509
mi
from
Graz,
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Miami, FL
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
New York, NY
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Northridge, CA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Albany, NY
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Anderson, SC
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Asheville, NC
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Bangor, ME
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Danville, VA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Decatur, GA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Greer, SC
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Hartford, CT
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Huntsville, AL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Nashua, NH
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Overland Park, KS
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
St. Cloud, MN
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Tipton, PA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Bell Gardens, CA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology Clinical Trial
Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab
Status: Enrolling, Phase I
Updated: 1/14/2016
mi
from
Denver, CO
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Altoona, PA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Aurora, IL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Bronx, NY
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Buffalo, NY
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Camden, NJ
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Cumming, GA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Elkhart, IN
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Fargo, ND
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Haverhill, MA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Hickory, NC
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Muncie, IN
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Panama City, FL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Plantation, FL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Rocky Mount, NC
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
San Diego, CA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Saratoga Springs, NY
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Smithtown, NY
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
West Chester, PA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Westwood, NJ
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Winfield, IL
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Auburn, ME
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Kansas City, KS
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Long Beach, CA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
Portland, OR
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling, Phase III
Updated: 1/11/2016
mi
from
St Louis, MO
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Anaheim, CA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Cortlandt Manor, NY
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Doylestown, PA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Fullerton, CA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Manassas, VA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Marquette, MI
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Mentor, OH
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Midland, MI
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Odessa, TX
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Pottstown, PA
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Rock Island, IL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Saginaw, MI
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Statesville, NC
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Troy, NY
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Wilmington, NC
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Clinical Trial
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Zanesville, OH
Click here to add this to my saved trials
1 8 9 10 11 12 13 14 15 16